Swiss cannabis pilot: pharmacy sales don't raise consumption, shift to safer use

Interim results from a Swiss regulated-cannabis pilot show no increase in overall consumption and a shift toward less risky consumption forms. The finding supports the policy's public-health rationale, though it is preliminary and based on a limited sample.